13D/13G Filings - BIOTECHNOLOGY VALUE FUND L P

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1, ...10, 11, 12, 13, 14, ...17, 18, Next
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2022-02-11
7:30 pm
Sale
2021-12-31 13G Corvus Pharmaceuticals, Inc.
CRVS
BIOTECHNOLOGY VALUE FUND L P 1,370,947
3.000%
-1,527,850decrease
(-52.71%)
Filing
History
2022-02-11
7:22 pm
Sale
2021-12-31 13G Merus N.V.
MRUS
BIOTECHNOLOGY VALUE FUND L P 4,135,071
9.600%
-925,000decrease
(-18.28%)
Filing
History
2022-01-31
5:07 pm
Purchase
2022-01-27 13D Kymera Therapeutics, Inc.
KYMR
BIOTECHNOLOGY VALUE FUND L P 3,586,658
7.000%
955,996increase
(+36.34%)
Filing
History
2022-01-28
4:35 pm
Purchase
2022-01-20 13G Eledon Pharmaceuticals, Inc.
ELDN
BIOTECHNOLOGY VALUE FUND L P 2,326,710
16.900%
878,690increase
(+60.68%)
Filing
History
2022-01-24
5:23 pm
Purchase
2022-01-13 13G Aclaris Therapeutics, Inc.
ACRS
BIOTECHNOLOGY VALUE FUND L P 3,868,043
6.300%
3,868,043increase
(New Position)
Filing
History
2022-01-18
5:18 pm
Purchase
2022-01-07 13G Sutro Biopharma, Inc.
STRO
BIOTECHNOLOGY VALUE FUND L P 3,160,416
6.800%
1,306,254increase
(+70.45%)
Filing
History
2022-01-12
5:05 pm
Purchase
2022-01-10 13G Molecular Partners AG
MOLN
BIOTECHNOLOGY VALUE FUND L P 4,526,282
14.100%
1,425,000increase
(+45.95%)
Filing
History
2022-01-12
5:03 pm
Purchase
2021-12-31 13G Molecular Partners AG
MOLN
BIOTECHNOLOGY VALUE FUND L P 3,101,282
9.700%
602,381increase
(+24.11%)
Filing
History
2022-01-11
5:13 pm
Purchase
2022-01-07 13D Rain Enhancement Technologies Holdco Inc
RAIN
BIOTECHNOLOGY VALUE FUND L P 3,526,729
18.800%
580,922increase
(+19.72%)
Filing
History
2022-01-10
5:57 pm
Purchase
2022-01-06 13G Eledon Pharmaceuticals, Inc.
ELDN
BIOTECHNOLOGY VALUE FUND L P 1,448,020
10.100%
13,088increase
(+0.91%)
Filing
History
2022-01-10
5:51 pm
Purchase
2021-12-31 13G Eledon Pharmaceuticals, Inc.
ELDN
BIOTECHNOLOGY VALUE FUND L P 1,434,932
9.990%
1,434,932increase
(New Position)
Filing
History
2022-01-10
4:52 pm
Purchase
2022-01-06 13G Verastem, Inc.
VSTM
BIOTECHNOLOGY VALUE FUND L P 1,542,180
10.200%
120,333increase
(+8.46%)
Filing
History
2022-01-10
4:49 pm
Purchase
2021-12-31 13G Verastem, Inc.
VSTM
BIOTECHNOLOGY VALUE FUND L P 1,421,847
9.400%
490,097increase
(+52.60%)
Filing
History
2022-01-03
4:34 pm
Purchase
2021-12-21 13G CytomX Therapeutics, Inc.
CTMX
BIOTECHNOLOGY VALUE FUND L P 5,803,700
8.900%
2,884,229increase
(+98.79%)
Filing
History
2021-12-20
5:23 pm
Purchase
2021-12-10 13G Pyxis Oncology, Inc.
PYXS
BIOTECHNOLOGY VALUE FUND L P 1,791,351
5.500%
1,791,351increase
(New Position)
Filing
History
2021-12-20
4:52 pm
Purchase
2021-12-16 13G Cullinan Oncology, Inc.
CGEM
BIOTECHNOLOGY VALUE FUND L P 4,394,459
10.100%
1,787,653increase
(+68.58%)
Filing
History
2021-12-20
4:51 pm
Purchase
2021-12-09 13G Relmada Therapeutics, Inc.
RLMD
BIOTECHNOLOGY VALUE FUND L P 1,647,400
5.900%
1,647,400increase
(New Position)
Filing
History
2021-12-16
5:16 pm
Purchase
2021-12-14 13G Cidara Therapeutics, Inc.
CDTX
BIOTECHNOLOGY VALUE FUND L P 343,056
10.300%
119,982increase
(+53.79%)
Filing
History
2021-12-02
5:05 pm
Purchase
2021-11-30 13D Olema Pharmaceuticals, Inc.
OLMA
BIOTECHNOLOGY VALUE FUND L P 7,411,503
18.400%
750,000increase
(+11.26%)
Filing
History
2021-11-15
4:58 pm
Purchase
2021-11-03 13G Concert Pharmaceuticals, Inc.
CNCE
BIOTECHNOLOGY VALUE FUND L P 3,596,757
9.990%
3,596,757increase
(New Position)
Filing
History
Goto Prev, 0, 1, ...10, 11, 12, 13, 14, ...17, 18, Next